BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jeppesen TD, Schwartz M, Olsen DB, Wibrand F, Krag T, Dunø M, Hauerslev S, Vissing J. Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 2006;129:3402-12. [PMID: 16815877 DOI: 10.1093/brain/awl149] [Cited by in Crossref: 138] [Cited by in F6Publishing: 117] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Morris G, Berk M, Galecki P, Walder K, Maes M. The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases. Mol Neurobiol 2016;53:1195-219. [PMID: 25598355 DOI: 10.1007/s12035-015-9090-9] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 11.4] [Reference Citation Analysis]
2 Wenz T, Diaz F, Hernandez D, Moraes CT. Endurance exercise is protective for mice with mitochondrial myopathy. J Appl Physiol (1985) 2009;106:1712-9. [PMID: 19286571 DOI: 10.1152/japplphysiol.91571.2008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
3 Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R, Medicine Society TM. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009;11:414-30. [PMID: 19891905 DOI: 10.1007/s11940-009-0046-0] [Cited by in Crossref: 187] [Cited by in F6Publishing: 164] [Article Influence: 17.0] [Reference Citation Analysis]
4 Chen L, Cui Y, Jiang D, Ma C, Tse H, Hwu W, Lian Q. Management of Leigh syndrome: Current status and new insights. Clinical Genetics 2018;93:1131-40. [DOI: 10.1111/cge.13139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Ostojic SM. Exercise-induced mitochondrial dysfunction: a myth or reality? Clin Sci (Lond) 2016;130:1407-16. [PMID: 27389587 DOI: 10.1042/CS20160200] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
6 Davis RL, Liang C, Sue CM. Mitochondrial diseases. Neurogenetics, Part I. Elsevier; 2018. pp. 125-41. [DOI: 10.1016/b978-0-444-63233-3.00010-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
7 Bergs PMJ, Maas DM, Janssen MCH, Groothuis JT. Feasible and clinical relevant outcome measures for adults with mitochondrial disease. Mol Genet Metab 2021:S1096-7192(21)01195-1. [PMID: 34961688 DOI: 10.1016/j.ymgme.2021.12.010] [Reference Citation Analysis]
8 Pepe S, Mentzer RM Jr, Gottlieb RA. Cell-permeable protein therapy for complex I dysfunction. J Bioenerg Biomembr 2014;46:337-45. [PMID: 25005682 DOI: 10.1007/s10863-014-9559-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 DeBalsi KL, Hoff KE, Copeland WC. Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases. Ageing Res Rev 2017;33:89-104. [PMID: 27143693 DOI: 10.1016/j.arr.2016.04.006] [Cited by in Crossref: 89] [Cited by in F6Publishing: 71] [Article Influence: 14.8] [Reference Citation Analysis]
10 Vorgerd M, Deschauer M. [Metabolic and mitochondrial myopathies]. Z Rheumatol 2013;72:242-54. [PMID: 23553022 DOI: 10.1007/s00393-012-1082-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Khan NA, Govindaraj P, Meena AK, Thangaraj K. Mitochondrial disorders: challenges in diagnosis & treatment. Indian J Med Res 2015;141:13-26. [PMID: 25857492 DOI: 10.4103/0971-5916.154489] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
12 Goldstein A, Wolfe LA. The elusive magic pill: finding effective therapies for mitochondrial disorders. Neurotherapeutics 2013;10:320-8. [PMID: 23355364 DOI: 10.1007/s13311-012-0175-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
13 Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts ACh. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2010;:CD003907. [PMID: 20091552 DOI: 10.1002/14651858.CD003907.pub3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
14 Taivassalo T, Ayyad K, Haller RG. Increased capillaries in mitochondrial myopathy: implications for the regulation of oxygen delivery. Brain 2012;135:53-61. [PMID: 22232594 DOI: 10.1093/brain/awr293] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
15 Pfeffer G, Horvath R, Klopstock T, Mootha VK, Suomalainen A, Koene S, Hirano M, Zeviani M, Bindoff LA, Yu-Wai-Man P, Hanna M, Carelli V, McFarland R, Majamaa K, Turnbull DM, Smeitink J, Chinnery PF. New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 2013;9:474-81. [PMID: 23817350 DOI: 10.1038/nrneurol.2013.129] [Cited by in Crossref: 120] [Cited by in F6Publishing: 103] [Article Influence: 13.3] [Reference Citation Analysis]
16 Steele HE, Horvath R, Lyon JJ, Chinnery PF. Monitoring clinical progression with mitochondrial disease biomarkers. Brain. 2017;140:2530-2540. [PMID: 28969370 DOI: 10.1093/brain/awx168] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
17 Venhoff N, Lebrecht D, Pfeifer D, Venhoff AC, Bissé E, Kirschner J, Walker UA. Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy. Arthritis Res Ther 2012;14:R233. [PMID: 23107834 DOI: 10.1186/ar4076] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
18 Mancuso M, Angelini C, Bertini E, Carelli V, Comi GP, Minetti C, Moggio M, Mongini T, Servidei S, Tonin P, Toscano A, Uziel G, Zeviani M, Siciliano G; Nation-wide Italian Collaborative Network of Mitochondrial Diseases. Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases. Neuromuscul Disord 2012;22 Suppl 3:S226-9. [PMID: 23182644 DOI: 10.1016/j.nmd.2012.10.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
19 Jeppesen TD, Schwartz M, Colding-jørgensen E, Krag T, Hauerslev S, Vissing J. Phenotype and clinical course in a family with a new de novo Twinkle gene mutation. Neuromuscular Disorders 2008;18:306-9. [DOI: 10.1016/j.nmd.2007.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
20 Porcelli S, Grassi B, Poole DC, Marzorati M. Exercise intolerance in patients with mitochondrial myopathies: perfusive and diffusive limitations in the O2 pathway. Current Opinion in Physiology 2019;10:202-9. [DOI: 10.1016/j.cophys.2019.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Murphy JL, Blakely EL, Schaefer AM, He L, Wyrick P, Haller RG, Taylor RW, Turnbull DM, Taivassalo T. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 2008;131:2832-40. [PMID: 18984605 DOI: 10.1093/brain/awn252] [Cited by in Crossref: 114] [Cited by in F6Publishing: 102] [Article Influence: 8.1] [Reference Citation Analysis]
22 Paik I, Jin C, Jin H, Kim Y, Cho S, Roh H, Suh A, Suh S. Effects of the NADPH oxidase p22phox C242T polymorphism on endurance exercise performance and oxidative DNA damage in response to aerobic exercise training. Mol Cells 2009;27:557-62. [DOI: 10.1007/s10059-009-0071-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Kley RA, Serdaroglu-Oflazer P, Leber Y, Odgerel Z, van der Ven PF, Olivé M, Ferrer I, Onipe A, Mihaylov M, Bilbao JM, Lee HS, Höhfeld J, Djinović-Carugo K, Kong K, Tegenthoff M, Peters SA, Stenzel W, Vorgerd M, Goldfarb LG, Fürst DO. Pathophysiology of protein aggregation and extended phenotyping in filaminopathy. Brain 2012;135:2642-60. [PMID: 22961544 DOI: 10.1093/brain/aws200] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
24 Fernández-de la Torre M, Fiuza-Luces C, Valenzuela PL, Laine-Menéndez S, Arenas J, Martín MA, Turnbull DM, Lucia A, Morán M. Exercise Training and Neurodegeneration in Mitochondrial Disorders: Insights From the Harlequin Mouse. Front Physiol 2020;11:594223. [PMID: 33363476 DOI: 10.3389/fphys.2020.594223] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Newell C, Ramage B, Robu I, Shearer J, Khan A. Side alternating vibration training in patients with mitochondrial disease: a pilot study. Arch Physiother 2017;7:10. [PMID: 29340204 DOI: 10.1186/s40945-017-0038-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2012;:CD004426. [PMID: 22513923 DOI: 10.1002/14651858.CD004426.pub3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 105] [Article Influence: 7.9] [Reference Citation Analysis]
27 Kerr DS. Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade. Mol Genet Metab 2010;99:246-55. [PMID: 20060349 DOI: 10.1016/j.ymgme.2009.11.005] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
28 Sveen ML, Andersen SP, Ingelsrud LH, Blichter S, Olsen NE, Jønck S, Krag TO, Vissing J. Resistance training in patients with limb-girdle and becker muscular dystrophies. Muscle Nerve 2013;47:163-9. [PMID: 23169433 DOI: 10.1002/mus.23491] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
29 Abresch RT, Carter GT, Han JJ, McDonald CM. Exercise in neuromuscular diseases. Phys Med Rehabil Clin N Am 2012;23:653-73. [PMID: 22938880 DOI: 10.1016/j.pmr.2012.06.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
30 Radak Z, Kumagai S, Nakamoto H, Goto S. 8-Oxoguanosine and uracil repair of nuclear and mitochondrial DNA in red and white skeletal muscle of exercise-trained old rats. J Appl Physiol (1985) 2007;102:1696-701. [PMID: 17204574 DOI: 10.1152/japplphysiol.01051.2006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
31 Zweers H, Smit D, Leij S, Wanten G, Janssen MC. Individual dietary intervention in adult patients with mitochondrial disease due to the m.3243 A>G mutation. Nutrition 2020;69:110544. [DOI: 10.1016/j.nut.2019.06.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Martens A, Gorter H, Wassink RGV, Rietman H. Physical Activity of Children With a Mitochondrial Disease Compared to Children Who Are Healthy. Pediatric Physical Therapy 2014;26:19-26. [DOI: 10.1097/pep.0000000000000016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Kisler JE, Whittaker RG, Mcfarland R. Mitochondrial diseases in childhood: a clinical approach to investigation and management: Review. Developmental Medicine & Child Neurology 2010;52:422-33. [DOI: 10.1111/j.1469-8749.2009.03605.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
34 Ben-Shachar D, Ene HM. Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders? Biol Psychiatry 2018;83:770-9. [PMID: 28965983 DOI: 10.1016/j.biopsych.2017.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
35 Fiuza-Luces C, Valenzuela PL, Laine-Menéndez S, Fernández-de la Torre M, Bermejo-Gómez V, Rufián-Vázquez L, Arenas J, Martín MA, Lucia A, Morán M. Physical Exercise and Mitochondrial Disease: Insights From a Mouse Model. Front Neurol 2019;10:790. [PMID: 31402893 DOI: 10.3389/fneur.2019.00790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
36 Nabben M, Schmitz JPJ, Ciapaite J, le Clercq CMP, van Riel NA, Haak HR, Nicolay K, de Coo IFM, Smeets H, Praet SF, van Loon LJ, Prompers JJ. Dietary nitrate does not reduce oxygen cost of exercise or improve muscle mitochondrial function in patients with mitochondrial myopathy. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2017;312:R689-701. [DOI: 10.1152/ajpregu.00264.2016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726 [PMID: 34904040 DOI: 10.4254/wjh.v13.i11.1707] [Reference Citation Analysis]
38 Fan HC, Lee HF, Yue CT, Chi CS. Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. Life (Basel) 2021;11:1111. [PMID: 34832987 DOI: 10.3390/life11111111] [Reference Citation Analysis]
39 Sellathurai J, Cheedipudi S, Dhawan J, Schrøder HD. A novel in vitro model for studying quiescence and activation of primary isolated human myoblasts. PLoS One 2013;8:e64067. [PMID: 23717533 DOI: 10.1371/journal.pone.0064067] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
40 Thornton B, Cohen B, Copeland W, Maria BL. Mitochondrial disease: clinical aspects, molecular mechanisms, translational science, and clinical frontiers. J Child Neurol 2014;29:1179-207. [PMID: 24916430 DOI: 10.1177/0883073814537379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
41 Anziska Y, Sternberg A. Exercise in neuromuscular disease. Muscle Nerve 2013;48:3-20. [PMID: 23695822 DOI: 10.1002/mus.23771] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
42 Gardner JL, Craven L, Turnbull DM, Taylor RW. Experimental Strategies Towards Treating Mitochondrial DNA Disorders. Bioscience Reports 2007;27:139-50. [DOI: 10.1007/s10540-007-9042-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
43 Memme JM, Hood DA. Molecular Basis for the Therapeutic Effects of Exercise on Mitochondrial Defects. Front Physiol 2020;11:615038. [PMID: 33584337 DOI: 10.3389/fphys.2020.615038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 de Barcelos IP, Emmanuele V, Hirano M. Advances in primary mitochondrial myopathies. Curr Opin Neurol 2019;32:715-21. [PMID: 31408013 DOI: 10.1097/WCO.0000000000000743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
45 Apabhai S, Gorman GS, Sutton L, Elson JL, Plötz T, Turnbull DM, Trenell MI. Habitual physical activity in mitochondrial disease. PLoS One 2011;6:e22294. [PMID: 21799815 DOI: 10.1371/journal.pone.0022294] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
46 Ringholm S, Biensø RS, Kiilerich K, Guadalupe-grau A, Aachmann-andersen NJ, Saltin B, Plomgaard P, Lundby C, Wojtaszewski JFP, Calbet JA, Pilegaard H. Bed rest reduces metabolic protein content and abolishes exercise-induced mRNA responses in human skeletal muscle. American Journal of Physiology-Endocrinology and Metabolism 2011;301:E649-58. [DOI: 10.1152/ajpendo.00230.2011] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
47 Jeppesen TD, Orngreen MC, Van Hall G, Vissing J. Lactate metabolism during exercise in patients with mitochondrial myopathy. Neuromuscul Disord 2013;23:629-36. [PMID: 23838278 DOI: 10.1016/j.nmd.2013.05.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
48 Féasson L, Verney J, Kadi F, Gautheron V, Calmels P, Millet GY. [Exercise therapy and myopathies]. Rev Neurol (Paris) 2010;166:269-78. [PMID: 19656541 DOI: 10.1016/j.neurol.2009.07.006] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
49 Soustek MS, Baligand C, Falk DJ, Walter GA, Lewin AS, Byrne BJ. Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome. J Inherit Metab Dis 2015;38:915-22. [PMID: 25860817 DOI: 10.1007/s10545-015-9834-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
50 McFarland R, Taylor RW, Turnbull DM. A neurological perspective on mitochondrial disease. Lancet Neurol 2010;9:829-40. [PMID: 20650404 DOI: 10.1016/S1474-4422(10)70116-2] [Cited by in Crossref: 177] [Cited by in F6Publishing: 90] [Article Influence: 14.8] [Reference Citation Analysis]
51 Newman J, Galna B, Jakovljevic DG, Bates MG, Schaefer AM, McFarland R, Turnbull DM, Trenell MI, Taylor RW, Rochester L, Gorman GS. Preliminary Evaluation of Clinician Rated Outcome Measures in Mitochondrial Disease. J Neuromuscul Dis 2015;2:151-5. [PMID: 27858729 DOI: 10.3233/JND-140061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
52 Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R; Mitochondrial Medicine Society Clinical Directors Working Group., Clinical Director's Work Group. Practice patterns of mitochondrial disease physicians in North America. Part 2: treatment, care and management. Mitochondrion 2013;13:681-7. [PMID: 24063850 DOI: 10.1016/j.mito.2013.09.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
53 Finsterer J, Bindu PS. Therapeutic strategies for mitochondrial disorders. Pediatr Neurol 2015;52:302-13. [PMID: 25701186 DOI: 10.1016/j.pediatrneurol.2014.06.023] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
54 Madsen KL, Buch AE, Cohen BH, Falk MJ, Goldsberry A, Goldstein A, Karaa A, Koenig MK, Muraresku CC, Meyer C, O'Grady M, Scaglia F, Shieh PB, Vockley J, Zolkipli-Cunningham Z, Haller RG, Vissing J. Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial. Neurology 2020;94:e687-98. [PMID: 31896620 DOI: 10.1212/WNL.0000000000008861] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
55 van Tienen F, Zelissen R, Timmer E, van Gisbergen M, Lindsey P, Quattrocelli M, Sampaolesi M, Mulder-den Hartog E, de Coo I, Smeets H. Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy. Stem Cell Res Ther 2019;10:405. [PMID: 31864395 DOI: 10.1186/s13287-019-1510-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Mouadil A, Debout C, Read MH, Morello R, Allouche S, Chapon F. Blood metabolite data in response to maximal exercise in healthy subjects. Clin Physiol Funct Imaging 2012;32:274-81. [PMID: 22681604 DOI: 10.1111/j.1475-097X.2012.01122.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
57 Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev. 2013;7:CD003907. [PMID: 23835682 DOI: 10.1002/14651858.cd003907.pub4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
58 Devries MC, Tarnopolsky MA. Muscle Physiology in Healthy Men and Women and Those with Metabolic Myopathies. Neurologic Clinics 2008;26:115-48. [DOI: 10.1016/j.ncl.2007.11.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
59 Jeppesen TD, Madsen KL, Poulsen NS, Løkken N, Vissing J. Exercise Testing, Physical Training and Fatigue in Patients with Mitochondrial Myopathy Related to mtDNA Mutations. J Clin Med 2021;10:1796. [PMID: 33924201 DOI: 10.3390/jcm10081796] [Reference Citation Analysis]
60 Fritzen AM, Andersen SP, Qadri KAN, Thøgersen FD, Krag T, Ørngreen MC, Vissing J, Jeppesen TD. Effect of Aerobic Exercise Training and Deconditioning on Oxidative Capacity and Muscle Mitochondrial Enzyme Machinery in Young and Elderly Individuals. J Clin Med 2020;9:E3113. [PMID: 32993104 DOI: 10.3390/jcm9103113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
61 Finsterer J, Zarrouk-Mahjoub S. Biomarkers for Detecting Mitochondrial Disorders. J Clin Med 2018;7:E16. [PMID: 29385732 DOI: 10.3390/jcm7020016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
62 Pfeffer G, Chinnery PF. Diagnosis and treatment of mitochondrial myopathies. Ann Med 2013;45:4-16. [PMID: 21867371 DOI: 10.3109/07853890.2011.605389] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
63 Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol 2010;5:297-348. [PMID: 20078222 DOI: 10.1146/annurev.pathol.4.110807.092314] [Cited by in Crossref: 431] [Cited by in F6Publishing: 395] [Article Influence: 35.9] [Reference Citation Analysis]
64 Bottani E, Lamperti C, Prigione A, Tiranti V, Persico N, Brunetti D. Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies. Pharmaceutics 2020;12:E1083. [PMID: 33187380 DOI: 10.3390/pharmaceutics12111083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
65 Das S, Morvan F, Jourde B, Meier V, Kahle P, Brebbia P, Toussaint G, Glass DJ, Fornaro M. ATP citrate lyase improves mitochondrial function in skeletal muscle. Cell Metab 2015;21:868-76. [PMID: 26039450 DOI: 10.1016/j.cmet.2015.05.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
66 Laforêt P, Nicolino M, Eymard B. Nouveautés dans le traitement des myopathies métaboliques. Revue Neurologique 2007;163:930-5. [DOI: 10.1016/s0035-3787(07)92636-3] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
67 Alaca N, Uslu S, Gulec Suyen G, Ince U, Serteser M, Kurtel H. Effects of different aerobic exercise frequencies on streptozotocin–nicotinamide‐induced type 2 diabetic rats: Continuous versus short bouts and weekend warrior exercises: 不同有氧运动频率对链脲霉素‐烟酰胺诱导的2型糖尿病大鼠的影响:持续运动与短时间运动以及周末运动的对照研究. Journal of Diabetes 2018;10:73-84. [DOI: 10.1111/1753-0407.12561] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
68 Fritzen AM, Thøgersen FB, Thybo K, Vissing CR, Krag TO, Ruiz-Ruiz C, Risom L, Wibrand F, Høeg LD, Kiens B, Duno M, Vissing J, Jeppesen TD. Adaptations in Mitochondrial Enzymatic Activity Occurs Independent of Genomic Dosage in Response to Aerobic Exercise Training and Deconditioning in Human Skeletal Muscle. Cells 2019;8:E237. [PMID: 30871120 DOI: 10.3390/cells8030237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
69 Schiff M, Bénit P, Jacobs HT, Vockley J, Rustin P. Therapies in inborn errors of oxidative metabolism. Trends Endocrinol Metab 2012;23:488-95. [PMID: 22633959 DOI: 10.1016/j.tem.2012.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
70 Gordon BS, Steiner JL, Rossetti ML, Qiao S, Ellisen LW, Govindarajan SS, Eroshkin AM, Williamson DL, Coen PM. REDD1 induction regulates the skeletal muscle gene expression signature following acute aerobic exercise. Am J Physiol Endocrinol Metab 2017;313:E737-47. [PMID: 28899858 DOI: 10.1152/ajpendo.00120.2017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
71 Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, Anselm I, Cohen BH, Falk MJ, Greene C, Gropman AL, Haas R, Hirano M, Morgan P, Sims K, Tarnopolsky M, Van Hove JL, Wolfe L, DiMauro S. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med 2015;17:689-701. [PMID: 25503498 DOI: 10.1038/gim.2014.177] [Cited by in Crossref: 226] [Cited by in F6Publishing: 169] [Article Influence: 28.3] [Reference Citation Analysis]
72 Cade WT, Reeds DN, Peterson LR, Bohnert KL, Tinius RA, Benni PB, Byrne BJ, Taylor CL. Endurance Exercise Training in Young Adults with Barth Syndrome: A Pilot Study. JIMD Rep 2017;32:15-24. [PMID: 27295193 DOI: 10.1007/8904_2016_553] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
73 Jeppesen TD, Duno M, Risom L, Wibrand F, Rafiq J, Krag T, Jakobsen J, Andersen H, Vissing J. A novel de novo mutation of the mitochondrial tRNAlys gene mt.8340G>a associated with pure myopathy. Neuromuscul Disord 2014;24:162-6. [PMID: 24161205 DOI: 10.1016/j.nmd.2013.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
74 Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial Diseases: Hope for the Future. Cell 2020;181:168-88. [PMID: 32220313 DOI: 10.1016/j.cell.2020.02.051] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 28.5] [Reference Citation Analysis]
75 Tuppen HA, Blakely EL, Turnbull DM, Taylor RW. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 2010;1797:113-28. [PMID: 19761752 DOI: 10.1016/j.bbabio.2009.09.005] [Cited by in Crossref: 378] [Cited by in F6Publishing: 331] [Article Influence: 29.1] [Reference Citation Analysis]
76 Vissing J, Angelini C. Remodel mitochondria and get energized. Neurology 2018;90:633-4. [PMID: 29500288 DOI: 10.1212/WNL.0000000000005243] [Reference Citation Analysis]
77 Gruosso F, Montano V, Simoncini C, Siciliano G, Mancuso M. Therapeutical Management and Drug Safety in Mitochondrial Diseases-Update 2020. J Clin Med 2020;10:E94. [PMID: 33383961 DOI: 10.3390/jcm10010094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Parikh S, Galioto R, Lapin B, Haas R, Hirano M, Koenig MK, Saneto RP, Zolkipli-cunningham Z, Goldstein A, Karaa A. Fatigue in primary genetic mitochondrial disease: No rest for the weary. Neuromuscular Disorders 2019;29:895-902. [DOI: 10.1016/j.nmd.2019.09.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
79 Glover EI, Martin J, Maher A, Thornhill RE, Moran GR, Tarnopolsky MA. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve 2010;42:739-48. [PMID: 20886510 DOI: 10.1002/mus.21758] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 7.2] [Reference Citation Analysis]
80 Menezes MJ, Riley LG, Christodoulou J. Mitochondrial respiratory chain disorders in childhood: Insights into diagnosis and management in the new era of genomic medicine. Biochimica et Biophysica Acta (BBA) - General Subjects 2014;1840:1368-79. [DOI: 10.1016/j.bbagen.2013.12.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
81 Tarnopolsky MA. Exercise as a therapeutic strategy for primary mitochondrial cytopathies. J Child Neurol 2014;29:1225-34. [PMID: 25008908 DOI: 10.1177/0883073814538512] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
82 Venturelli M, Villa F, Ruzzante F, Tarperi C, Rudi D, Milanese C, Cavedon V, Fonte C, Picelli A, Smania N, Calabria E, Skafidas S, Layec G, Schena F. Neuromuscular and Muscle Metabolic Functions in MELAS Before and After Resistance Training: A Case Study. Front Physiol 2019;10:503. [PMID: 31105594 DOI: 10.3389/fphys.2019.00503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Garone C, Minczuk M, Carelli V, La Morgia C. Clinical syndromes associated with mtDNA mutations: where we stand after 30 years. Essays in Biochemistry 2018;62:235-54. [DOI: 10.1042/ebc20170097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
84 Tarnopolsky MA, Nilsson MI. Nutrition and exercise in Pompe disease. Ann Transl Med 2019;7:282. [PMID: 31392194 DOI: 10.21037/atm.2019.05.52] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
85 Lioncino M, Monda E, Caiazza M, Fusco A, Cirillo A, Dongiglio F, Simonelli V, Sampaolo S, Ruggiero L, Scarano G, Pota V, Frisso G, Mazzaccara C, D'Amati G, Nigro G, Russo MG, Wahbi K, Limongelli G. Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options. Heart Fail Clin 2022;18:51-60. [PMID: 34776083 DOI: 10.1016/j.hfc.2021.07.003] [Reference Citation Analysis]
86 Vissing J, van Engelen BG. 160th ENMC International Workshop (First ENMC practical care workshop) Exercise training in patients with muscle diseases. Neuromuscular Disorders 2013;23:182-7. [DOI: 10.1016/j.nmd.2012.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
87 Jeppesen TD. Aerobic Exercise Training in Patients With mtDNA-Related Mitochondrial Myopathy. Front Physiol 2020;11:349. [PMID: 32508662 DOI: 10.3389/fphys.2020.00349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Jeppesen TD, Dunø M, Schwartz M, Krag T, Rafiq J, Wibrand F, Vissing J. Short- and long-term effects of endurance training in patients with mitochondrial myopathy. Eur J Neurol 2009;16:1336-9. [PMID: 19486129 DOI: 10.1111/j.1468-1331.2009.02660.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
89 Porcelli S, Marzorati M, Morandi L, Grassi B. Home-based aerobic exercise training improves skeletal muscle oxidative metabolism in patients with metabolic myopathies. J Appl Physiol (1985) 2016;121:699-708. [PMID: 27445303 DOI: 10.1152/japplphysiol.00885.2015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
90 Schreuder LT, Nijhuis-van der Sanden MW, de Hair A, Peters G, Wortmann S, Bok LA, Morava E. Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction. J Inherit Metab Dis 2010;33 Suppl 3:S205-9. [PMID: 20443062 DOI: 10.1007/s10545-010-9085-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
91 Wabbels B, Ali N, Kunz W, Roggenkämper P, Kornblum C. Chronisch-progressive externe Ophthalmoplegie und Kearns-Sayre-Syndrom: Interdisziplinäre Diagnostik und Therapie. Ophthalmologe 2008;105:550-6. [DOI: 10.1007/s00347-007-1643-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
92 Hou Y, Xie Z, Zhao X, Yuan Y, Dou P, Wang Z. Appendicular skeletal muscle mass: A more sensitive biomarker of disease severity than BMI in adults with mitochondrial diseases. PLoS One 2019;14:e0219628. [PMID: 31344055 DOI: 10.1371/journal.pone.0219628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
93 Soldath P, Madsen KL, Buch AE, Duno M, Wibrand F, Vissing J. Pure exercise intolerance and ophthalmoplegia associated with the m.12,294G > A mutation in the MT-TL2 gene: a case report. BMC Musculoskelet Disord 2017;18:419. [PMID: 29052516 DOI: 10.1186/s12891-017-1781-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
94 Set KK, Sen K, Huq AHM, Agarwal R. Mitochondrial Disorders of the Nervous System: A Review. Clin Pediatr (Phila) 2019;58:381-94. [PMID: 30607979 DOI: 10.1177/0009922818821890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Coppi L, Ligorio S, Mitro N, Caruso D, De Fabiani E, Crestani M. PGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism. Int J Mol Sci 2021;22:6913. [PMID: 34199142 DOI: 10.3390/ijms22136913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
96 Hassani A, Horvath R, Chinnery PF. Mitochondrial myopathies: developments in treatment. Current Opinion in Neurology 2010;23:459-65. [DOI: 10.1097/wco.0b013e32833d1096] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
97 Koene S, Smeitink J. Mitochondrial medicine: entering the era of treatment. J Intern Med 2009;265:193-209. [PMID: 19192036 DOI: 10.1111/j.1365-2796.2008.02058.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
98 Siciliano G, Simoncini C, Lo Gerfo A, Orsucci D, Ricci G, Mancuso M. Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. Neuromuscul Disord 2012;22 Suppl 3:S172-7. [PMID: 23182634 DOI: 10.1016/j.nmd.2012.10.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
99 Bates MG, Newman JH, Jakovljevic DG, Hollingsworth KG, Alston CL, Zalewski P, Klawe JJ, Blamire AM, MacGowan GA, Keavney BD, Bourke JP, Schaefer A, McFarland R, Newton JL, Turnbull DM, Taylor RW, Trenell MI, Gorman GS. Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease. Int J Cardiol 2013;168:3599-608. [PMID: 23742928 DOI: 10.1016/j.ijcard.2013.05.062] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
100 Koňaříková E, Marković A, Korandová Z, Houštěk J, Mráček T. Current progress in the therapeutic options for mitochondrial disorders. Physiol Res 2020;69:967-94. [PMID: 33129249 DOI: 10.33549/physiolres.934529] [Reference Citation Analysis]
101 Leong PK, Wong HS, Chen J, Ko KM. Yang/Qi invigoration: an herbal therapy for chronic fatigue syndrome with yang deficiency? Evid Based Complement Alternat Med 2015;2015:945901. [PMID: 25763095 DOI: 10.1155/2015/945901] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
102 Tinker RJ, Lim AZ, Stefanetti RJ, McFarland R. Current and Emerging Clinical Treatment in Mitochondrial Disease. Mol Diagn Ther 2021;25:181-206. [PMID: 33646563 DOI: 10.1007/s40291-020-00510-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
103 Montes J, Garber CE, Kramer SS, Montgomery MJ, Dunaway S, Kamil-Rosenberg S, Carr B, Cruz R, Strauss NE, Sproule D, De Vivo DC. Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative? J Neuromuscul Dis 2015;2:463-70. [PMID: 27858749 DOI: 10.3233/JND-150101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
104 Vissing CR, Hedermann G, Vissing J. Moderate-intensity aerobic exercise improves physical fitness in bethlem myopathy. Muscle Nerve 2019;60:183-8. [PMID: 31026058 DOI: 10.1002/mus.26498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Geto Z, Molla MD, Challa F, Belay Y, Getahun T. Mitochondrial Dynamic Dysfunction as a Main Triggering Factor for Inflammation Associated Chronic Non-Communicable Diseases. J Inflamm Res 2020;13:97-107. [PMID: 32110085 DOI: 10.2147/JIR.S232009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
106 Grady JP, Murphy JL, Blakely EL, Haller RG, Taylor RW, Turnbull DM, Tuppen HA. Accurate measurement of mitochondrial DNA deletion level and copy number differences in human skeletal muscle. PLoS One 2014;9:e114462. [PMID: 25474153 DOI: 10.1371/journal.pone.0114462] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
107 Oliveira AN, Richards BJ, Slavin M, Hood DA. Exercise Is Muscle Mitochondrial Medicine. Exerc Sport Sci Rev 2021;49:67-76. [PMID: 33720909 DOI: 10.1249/JES.0000000000000250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Zorov DB, Isaev NK, Plotnikov EY, Silachev DN, Zorova LD, Pevzner IB, Morosanova MA, Jankauskas SS, Zorov SD, Babenko VA. Perspectives of mitochondrial medicine. Biochemistry (Mosc) 2013;78:979-90. [PMID: 24228919 DOI: 10.1134/S0006297913090034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
109 Horvath R, Gorman G, Chinnery PF. How can we treat mitochondrial encephalomyopathies? Approaches to therapy. Neurotherapeutics 2008;5:558-68. [PMID: 19019307 DOI: 10.1016/j.nurt.2008.07.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
110 Ahmed ST, Craven L, Russell OM, Turnbull DM, Vincent AE. Diagnosis and Treatment of Mitochondrial Myopathies. Neurotherapeutics 2018;15:943-53. [PMID: 30406383 DOI: 10.1007/s13311-018-00674-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
111 Gimenes AC, Bravo DM, Nápolis LM, Mello MT, Oliveira AS, Neder JA, Nery LE. Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy. Braz J Med Biol Res 2015;48:354-62. [PMID: 25714882 DOI: 10.1590/1414-431X20143467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
112 Zweers HEE, Bordier V, In 't Hulst J, Janssen MCH, Wanten GJA, Leij-Halfwerk S. Association of Body Composition, Physical Functioning, and Protein Intake in Adult Patients With Mitochondrial Diseases. JPEN J Parenter Enteral Nutr 2021;45:165-74. [PMID: 32189351 DOI: 10.1002/jpen.1826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Russell AP, Foletta VC, Snow RJ, Wadley GD. Skeletal muscle mitochondria: a major player in exercise, health and disease. Biochim Biophys Acta 2014;1840:1276-84. [PMID: 24291686 DOI: 10.1016/j.bbagen.2013.11.016] [Cited by in Crossref: 130] [Cited by in F6Publishing: 121] [Article Influence: 14.4] [Reference Citation Analysis]
114 Parodi S, Pennuto M. Neurotoxic effects of androgens in spinal and bulbar muscular atrophy. Frontiers in Neuroendocrinology 2011;32:416-25. [DOI: 10.1016/j.yfrne.2011.06.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
115 Shiotani H, Umegaki Y, Tanaka M, Kimura M, Ando H. EFFECTS OF AEROBIC EXERCISE ON THE CIRCADIAN RHYTHM OF HEART RATE AND BLOOD PRESSURE. Chronobiology International 2009;26:1636-46. [DOI: 10.3109/07420520903553443] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
116 Voet NB, van der Kooi EL, van Engelen BG, Geurts AC. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2019;12:CD003907. [PMID: 31808555 DOI: 10.1002/14651858.CD003907.pub5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
117 Laforêt P, Vianey-saban C, Vissing J. 162nd ENMC International Workshop: Disorders of muscle lipid metabolism in adults 28–30 November 2008, Bussum, The Netherlands. Neuromuscular Disorders 2010;20:283-9. [DOI: 10.1016/j.nmd.2010.01.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
118 Rowe GC, El-Khoury R, Patten IS, Rustin P, Arany Z. PGC-1α is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle. PLoS One 2012;7:e41817. [PMID: 22848618 DOI: 10.1371/journal.pone.0041817] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 8.2] [Reference Citation Analysis]
119 Wallace A, Pietrusz A, Dewar E, Dudziec M, Jones K, Hennis P, Sterr A, Baio G, Machado PM, Laurá M, Skorupinska I, Skorupinska M, Butcher K, Trenell M, Reilly MM, Hanna MG, Ramdharry GM. Community exercise is feasible for neuromuscular diseases and can improve aerobic capacity. Neurology 2019;92:e1773-85. [PMID: 30850441 DOI: 10.1212/WNL.0000000000007265] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
120 Abresch RT, Han JJ, Carter GT. Rehabilitation Management of Neuromuscular Disease: The Role of Exercise Training. Journal of Clinical Neuromuscular Disease 2009;11:7-21. [DOI: 10.1097/cnd.0b013e3181a8d36b] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
121 Viscomi C, Bottani E, Zeviani M. Emerging concepts in the therapy of mitochondrial disease. Biochim Biophys Acta 2015;1847:544-57. [PMID: 25766847 DOI: 10.1016/j.bbabio.2015.03.001] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 10.7] [Reference Citation Analysis]
122 Smits B, van den Heuvel L, Knoop H, Küsters B, Janssen A, Borm G, Bleijenberg G, Rodenburg R, van Engelen B. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion 2011;11:735-8. [PMID: 21664495 DOI: 10.1016/j.mito.2011.05.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]